You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

15 Results
Guidelines and Advice
Status: Archived
ID: 6-14
Dec 2008
Guidelines and Advice
Status: Current
ID: ES PET 20
Apr 2022
Guidelines and Advice
Status: Archived
ID: CED 8
Jul 2008
Guidelines and Advice
Status: Archived
ID: CED 10
Sep 2008
Guidelines and Advice
Status: Archived
ID: CED 7
Feb 2008
Guidelines and Advice
Status: Archived
ID: CED 9
Aug 2008
Guidelines and Advice
Status: Archived
ID: 1-13
Sep 2008
Guidelines and Advice
Status: Archived
ID: 3-19
Feb 2008
Guidelines and Advice
Status: Archived
ID: 16-2
Mar 2008
Guidelines and Advice
Status: Archived
ID: 6-9
Jan 2008
Regimen
Cancer Type:
Gynecologic, 
Cervix
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Bevacizumab (Biosimilar) - Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
PACLitaxel,
CISplatin,
bevacizumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Apr 2022
Guidelines and Advice
Status: Education and Information
ID: 19-2
Mar 2008

Pages